These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36059267)

  • 1. Informed Decision Making for Anticoagulation Therapy for Atrial Fibrillation.
    Martinez KA; Linfield DT; Shaker V; Rothberg MB
    Med Decis Making; 2023 Feb; 43(2):263-269. PubMed ID: 36059267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative Analysis of Patient-Physician Discussions Regarding Anticoagulation for Atrial Fibrillation.
    Martinez KA; Hurwitz HM; Rothberg MB
    JAMA Intern Med; 2022 Dec; 182(12):1260-1266. PubMed ID: 36315125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
    Carnicelli AP; Hong H; Connolly SJ; Eikelboom J; Giugliano RP; Morrow DA; Patel MR; Wallentin L; Alexander JH; Cecilia Bahit M; Benz AP; Bohula EA; Chao TF; Dyal L; Ezekowitz M; A A Fox K; Gencer B; Halperin JL; Hijazi Z; Hohnloser SH; Hua K; Hylek E; Toda Kato E; Kuder J; Lopes RD; Mahaffey KW; Oldgren J; Piccini JP; Ruff CT; Steffel J; Wojdyla D; Granger CB;
    Circulation; 2022 Jan; 145(4):242-255. PubMed ID: 34985309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease.
    Ruiz Vargas E; Sposato LA; Lee SAW; Hachinski V; Cipriano LE
    Stroke; 2018 Dec; 49(12):2844-2850. PubMed ID: 30571418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Preferences Between Clinicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation.
    Rymer JA; Webb L; McCall D; Hills MT; Wang TY
    J Am Heart Assoc; 2021 Jun; 10(11):e020697. PubMed ID: 33998252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.
    Kaiser K; Cheng WY; Jensen S; Clayman ML; Thappa A; Schwiep F; Chawla A; Goldberger JJ; Col N; Schein J
    Curr Med Res Opin; 2015 Dec; 31(12):2261-72. PubMed ID: 26390360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Web-based education resources informing patients about stroke prevention in atrial fibrillation.
    Pandya E; Bajorek BV
    J Clin Pharm Ther; 2016 Dec; 41(6):667-676. PubMed ID: 27704588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' and physicians' experiences of atrial fibrillation consultations and anticoagulation decision-making: A multi-perspective IPA design.
    Borg Xuereb C; Shaw RL; Lane DA
    Psychol Health; 2016; 31(4):436-55. PubMed ID: 26540308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US.
    Sullivan PW; Arant TW; Ellis SL; Ulrich H
    Pharmacoeconomics; 2006; 24(10):1021-33. PubMed ID: 17002484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of patients' preferences on the treatment of atrial fibrillation: observational study of patient-based decision analysis.
    Protheroe J; Fahey T; Montgomery AA; Peters TJ
    West J Med; 2001 May; 174(5):311-5. PubMed ID: 11342503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives.
    Alonso-Coello P; Montori VM; Díaz MG; Devereaux PJ; Mas G; Diez AI; Solà I; Roura M; Souto JC; Oliver S; Ruiz R; Coll-Vinent B; Gich I; Schünemann HJ; Guyatt G
    Health Expect; 2015 Dec; 18(6):2318-27. PubMed ID: 24813058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.
    Sciria CT; Maddox TM; Marzec L; Rodwin B; Virani SS; Annapureddy A; Freeman JV; O'Hare A; Liu Y; Song Y; Doros G; Zheng Y; Lee JJ; Daggubati R; Vadlamani L; Cannon C; Desai NR
    Clin Cardiol; 2020 Jul; 43(7):743-751. PubMed ID: 32378265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential use of decision analysis to support shared decision making in the face of uncertainty: the example of atrial fibrillation and warfarin anticoagulation.
    Robinson A; Thomson RG;
    Qual Health Care; 2000 Dec; 9(4):238-44. PubMed ID: 11101709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
    J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for Patients with Atrial Fibrillation and Cerebral Microbleeds.
    Badi MK; Vilanilam GK; Gupta V; Barrett KM; Lesser ER; Cochuyt JJ; Hodge DO; Brott TG; Meschia JF
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2159-2167. PubMed ID: 31103554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
    Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS
    Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.
    Eckman MH; Wise RE; Naylor K; Arduser L; Lip GY; Kissela B; Flaherty M; Kleindorfer D; Khan F; Schauer DP; Kues J; Costea A
    Curr Med Res Opin; 2015 Apr; 31(4):603-14. PubMed ID: 25690491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service-a cross-sectional study of patients in a Canadian Health Region.
    Bonsu KO; Young SW; Lee T; Nguyen HV; Chitsike RS
    Eur J Clin Pharmacol; 2023 Jan; 79(1):117-125. PubMed ID: 36399203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.